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Abstract 
The research includes a clinical study of Arginase and its relation with uterine fibroid. The normal value of 
arginase activity in female serum was found to be (0.52 ± 0.02 IU/L) in healthy group at age (35-55) years. The 
study also showed a highly significant increase in arginase activity (7.99 ± 0.23 IU/L) in serum of uterine fibroid 
patients group at (35-55years) in comparison to healthy.The results also indicated a highly significant increase in 
the level of progesterone, estradiol, prolactin, peroxynitrite and malondialdehyde in patients group. While a 
highly significant decrease in concentration of adiponectin in patients group was found in comparison to healthy. 
Keywords: Arg , Adipo Q, PRO, E2, PRL, Peroxynitrite, MDA. 
Abbreviations: Arg, Arginase; Adipo Q, Adoponectin; PRO, Progesterone; E2, Estradiol; PRL, Prolactin; MDA, 
Malondialdehyde. 
 
Introduction 
Uterine fibroids are benign (not cancer) tumors
(1)
 growths that develop from the muscle tissue of the uterus
(2)
. 
They also are called leiomyomas, myomas, fibromyomas, leiomyofibromas. Because the tumor consists of 
uterine smooth tissue as well as fibroids tissue, the term fibroid does not adequately capture the name of the 
lesion
(3).
. These tumors have prevalence ranging from 20% to 40% of the women depending on the age
(4)
. 
Uterine fibroids can cause severe problems for women and most of the uterine fibroids do not cause symptoms 
(5)
. 
The size, shape and location of fibroid vary greatly
(6)
. The may be present inside the uterus, on its outer surface 
or within its wall, or attached to it by a stem
(7)
. 
The aim of this study were to determine arginase activity in serum of females with uterine fibroid and 
its relationship with adiponectin, progesterone, estrodiol, prolactin, peroxynitrite and malonaldehyde. 
The causes of the uterine fibroids may be attributed to the genetic change
(8)
.hormones (estrogen and 
progesterone)
(9)
 and other growth factors such as insulin-like growth factor
(10)
. 
Arginase belongs to the urea hydrolase family of enzyme. The arginase (EC. 3.5. 3.1), catalyzes the 
fifth and final step in the urea cycle, a series of biochemical reactions in mammals during which the body disposes 
of harmful ammonia. Specifically, arginase-convert L-arginase into L-ornithine and urea
(11)
. 
Adiponectin is a protein hormone that modulates a number of metabolic processes, including glucose 
regulation and oxidation
(12)
. Therefore, adiponectin has multiple functions including anti oxidation and 
antiflamation potential
(13)
. Indeed, some investigators have indicated that how circulating adiponectin levels may 
be associated with pathogenesis of liver cancer, adiponectin is abundantly expressed and secreted by adipose 
tissue, and circulates as different multimer complexes
(14)
. Multimer complex formation of adiponectin, as a major 
biological functions of this adipocytokine
(15)
. 
Oxidative stress can be identified as an imbalance between the oxidant materials (free radical and their 
metabolism outputs) and antioxidants. The cells contain oxidant materials more than antioxidants, which is lead to 
destroy the big vital molecules of the body. Oxidative stress happens when the level of oxidant compounds exceed 
the ability of antioxidants on removing it
(16)
. 
 
Materials and Methods  
Subjects 
In this study were collected during the period from 1
st
 Dec. 2013 until the end of May 2014 at obstetrics and 
gynecology deportment of two hospitals in Baghdad city (Baghdad teaching hospital and Al-Yarmuk teaching 
hospital). The females included two groups, patients and healthy. The patients group consisted of (50) females 
with uterine fibroids were diagnosed by ultrasound. The healthy group consisted of (30) females as control, two 
groups aged (30-55) years. 
 
Specimens collection and analysis 
Venous blood samples were drown from each patient then transferred immediately to a clean dry plain tube. 
After removing the needle, the blood was allowed to clot for at least (10-15) min, at room temperature and then 
centrifuged for (15) min, at (3500 rpm). Serum is removed and assayed immediately and store the samples at 
4°C for the purpose of conducting the required measurements. 
Methods 
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Arginase activity was measured in serum according to (Coulomble., 1963)
(17)
. Serum adiponectin, progesterone, 
estradiol and prolactin levels were measured using an enzyme- linked immunosorbent assay. Peroxynitrite 
(ONOO
-
)was measured by the modified method described by (Vanuffelenet al., 1998)
(18)
 based on the ability of 
peroxynitrite to convert the phenol to nitrophenol which can be estimated spectrophotometrically. Serum MDA 
was measured by a modified method described by (Schmede and Holmer.,1989)
(19)
 using thiobarbituric acid. 
 
Results 
The results of the measured biochemical parameters are summarized in the table (1). The result showed a 
significant increase (p˂0.000) in level of arginase, progesterone, estradiol, prolactin, peroxynitrite and MDA in 
serum of uterine fibroid females compared to healthy females. There was a significant decrease (p˂0.000) in 
adiponectin levels in sera females with uterine fibroid compared to healthy ones. 
 
Table (1): Values of biochemical parameters in females of uterine fibroid and healthy females. 
Biochemical parameters 
Healthy females (n=30) Uterine fibroid females (n=50) 
Mean ± SE Mean ± SE 
Arginase (IU/L) 0.52 ± 0.02 7.99 ± 0.23* 
Adiponectin (ng/mL) 16.93 ± 0.29 13.22 ± 0.12* 
Progesterone (ng/mL) 0.95 ± 0.05 2.07 ± 0.06* 
Estradiol (pg/mL) 107.39 ± 3.93 265.42 ± 6.37* 
Prolactin (ng/mL) 8.57 ± 0.21 17.13 ± 0.38* 
Peroxynitrite(µmol/L) 45.16 ± 0.86 83.29 ± 0.4* 
MDA (mmol/L) 0.67 ± 0.04 3.01 ± 0.07* 
*Significant differences at (p˂0.0001)  
 
Discussion 
Arginase can redirect the metabolism of L-arginine in smooth muscle cells from nitric oxide (NO) to L-ornithine 
and the formation of polyamines and L-proline, which can induce vascular lesion formation by stimulating 
smooth muscle cell proliferation and collagen deposition. These action of arginase are further magnified by the 
suppression of NO release, which serves as a well recognized inhibitor of smooth muscle cell growth and 
collagen synthesis 
(20)
. 
While (Kaplan et al., 2012)
(21)
, refered to that increased arginase activity may limit nitric oxide 
synthase (NOS) activity and lead to a weaking of the inhibitor effect on xanthine oxidase activity. In this case, it 
result in more superoxide radical production and tissue damage. 
As evidenced by the up regulation of arginase in specific disease states, its distribution in vagina and its 
modulation by sex steroid hormones, this enzyme my also tissue growth fibrosis, and immune function
(22)
. On 
other hand, the reason of high arginase activity may be attributed to change in permeability of fibroid cell as a 
result of many biochemical changes in cell surface, that is included changes in appearance of cell surface such as 
variation in glycolipid and mucine. Like in this alter leads to excrete several of enzymes from cells to serum and 
one of these enzymes is arginase
(23)
. 
The present study found a significantly decrease (p˂0.000) of serum adiponectin levels in uterine 
fibroids females than levels of healthy group. The results are agreement with (Chen et al., 2004)
(24)
 results, in 
which it was found a significant decrease in adiponectin level. The repression of adiponectin on leiomyoma cell 
proliferation in the rat mat explain a crucial role of adeponectin in the association of metabolic syndrome with 
uterine leiomyoma
(25)
. Serum adiponectin levels are decreased in women with uterine leiomyomas and play a 
possible role in the pathogenesis of leiomyomas, therough insulin-or estrogen-related pathways
(24)
. Adiponectin 
plays an important role in regulation several metabolic pathways, involving glucose and fatty acid catabolism; low 
levels of the hormone have been implicated in the development of metabolic syndrome and type 2 diabetes,which 
are condition also associated with a higher risk of fibroid development. It has been found that adiponectin inhibits 
rats uterine leiomyoma cell growth in a dose- dependent faslnion. Thus, pathways associated with adiponectin 
could possibly serve as therapeutic targets against fibroid development in the future
(1)
. Adiponectinplays an 
important role in human reproduction system and fertility of women. Adiponectin concentration decreases in 
women with endometriosis and endometrial cancer
(26)
. Both (Rasulet al., 2011 and Koncsoset al., 2010)
(27,28)
. 
Were pointed at the low level of adiponectin become macrophages in adipose tissue more efficiently and produce 
large amount of inflammatory cytokines andit is adiponectin anti- inflammatory. During our reading for similar 
studies, we found that because it's role as anti-proliferation for leiomyoma cells, adiponectin level was expected to 
be decreased in sera of females with uterine fibroids (The relationship between adiponectin and fibroids is 
reverse). 
The results in table (1) showed a highly significant increase (p˂0.000) of serum progesterone levels in 
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uterine fibroid  patients than levels of healthy group. The results are agreement with other investigators (Englurdet 
al., 1998; Nisolle et al., 1999)
(29,30)
. Which showed uterine fibroid have increased concentration of progesterone 
receptors A and B compared with normal myometrium. The highest mitotic counts are found during the secretory 
phase at peak of progesterone production, and mitotic counts are higher in women treat with medroxy 
progesterone acetate (MPA) than in untreated controls (Kawaguchi et al., 1991)
(31)
. Gonadotropin releasing 
hormone (GnRH) agonists decrease the size of uterine fibroids, but progestin given concurrently with GnRH 
prevents a decrease in size
(32)
. 
Table (1) showed a highly significant increase in estradiol level in serum of uterine fibroid females 
(p˂0.000) when compared with healthy females. The obtained results were in agreement with those reported by 
other (Mac Mahon el al., 1982; Apter et al., 1989; Moor et al, 1991)
(33-35)
. Which showed a levels of estradiol 
within uterine fibroid are higher than in normal myometrium. Consistent with idea, uterine fibroid show a higher 
proliferative index than normal myometrium throught the menstrual cycle. (Cook & Walker, 2004)
(36)
. The 
patients who had higher levels of estradiol also had earlier menarche than the controls. Likewise, estradiol levels 
have been observed to be higher among nulliparous women than amongparous women (Bernstinet al.,1991)
(37)
and 
to increase with age (up to 40 years) during the mid-cycle and luteal menstrual phase among nulliparous women 
but to decline with age among parous women. (Dorgan et al., 1995)
(38)
. 
The statistical analysis showed that there is a highly significant increase in prolactin level serum of 
uterine fibroid females (p˂0.000) when compared with the healthy females. This finding is in agreement with 
(Mitchell et al., 1989) 
(39)
. Which showed that, the level of prolactin is higher in uterine fibroid 
patients.Leiomyoma has the ability to synthesize prolactin which increase the evidence that cells of mesenchymal 
origin that arise near the paramesone-phric ducts have a lantentability  to express the genome for prolactin 
synthesis in leiomayoma in vivo suggest that this potential genome expression is activated either in smooth muscle 
cells or stromal cells during the transformation of normal cell to leiomyoma cells (Daly et al., 1984) 
(40)
. 
The increase in the levels of the free radicals nitric oxide (NO·) and super oxide (O2·
-
) produced 
ONOO
-
 may be occur in uterine fibroid. The results in table (1) showed a highly significant elevation in 
peroxynitrite in the serum of uterine fibroid females compared with healthy females. The increase of peroxynitrite 
might be due to excess of O2·
-
 which is formed as a result of reaction between NO· and O2·
-
. (Paul et al., 1998) 
(41)
. 
Table (1) showed that there is a highly significant increase in MDA concentration in serum of uterine 
fibroid females (p˂0.000) when compared with the healthy females. These result were in agreement with other 
investigations (Pejicet al., 2009)
(42)
. Which showed an increase in concentration of lipid preoxidation products, as 
marker of oxidative stress whereas the level of antioxidants decreased in uterine fibroid patients. The rise in MDA 
concentration could be due to in increased generation of (ROS) due to the excessive oxidative damage generation 
in uterine fibroids patients, oxygen radical production, which increased with clinical progression of diseases 
involves increased lipid peroxidation, as a result of which there are cellular membrane degeneration and DNA 
damage (Pejicet al., 2006)
(43)
. Finally increase in levels of MDA indicated the upsurged lipid peroxidation as a 
consequence of the increase in free radical generation, thee free radical may cause profound alteration in the 
function of the cell membrane and also structural organization of DNA leading to mutation, therefore, it can be 
stated that lipid peroxidation product is one of the possible causes of uterine fibroid progression (Bilal, K.M., 
2013)
(44)
. Oxidative stress plays a key role in numerous such as chronic inflammatory diseases (Kavianet al., 
2012)
(45)
. In endometriosis, a metastatic benign disease (Borghese et al., 2010)
(46)
, endometriotic cells display an 
increase in endogenous oxidative stress with ROS produced in excess and failures in ROS detoxification pathways 
(Leconteet al.,2011)
(47).
In neoplastic condition, the intracellular redox status controls tumor cell proliferation 
(Alexandreet al., 2006) 
(48)
, and enhances the metastatic potential of tumor cells (Ishikawa et al., 2008) 
(49)
. 
Estrogen as well as estrogen metabolites have been reported to act as pro-oxidants(Bolton et al.,2002)
(50)
. Estrogen 
induced ROS play important roles in cell transformation, cell proliferation migration and invasion by increasing 
genomic instability and influencing redox sensitive transcription factors(Okohet al., 2011)
(51)
.  Several reports 
have suggested the role of the oxidative stress in the development of uterine leiomyomas in the present study we 
assayed serum oxidative stress marker in a large of females with uterine leiomyomas(Vurlet al., 2012)
(52)
.  
 
Conclusion 
These data suggest that arginase activity increased in subjects with uterine fibroid. Decreased in adiponectin 
levels also recorded in this study, that may resulted from the effect of elevation in lipid peroxidation on the 
permeability of cell membrane, and the high concentration of the hormones (progesterone, estradiol and 
prolactin).  
The present study suggests that arginase may serve as an indicator uterine fibroid. As our knowledge, 
no previous studies have showed these results in uterine fibroid. 
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